Key points are not available for this paper at this time.
Identification of biomarkers is required for a systems medicine approach and personalized treatment in atopic dermatitis (AD). These biomarkers may not only aid in diagnosing but also might be suitable to predict the effectiveness of targeted treatment.
Pažur et al. (Tue,) studied this question.